A new study led by researchers at McMaster University reveals that hidden fat deep inside the abdomen and liver may quietly damage arteries, even in people who appear healthy.This article was originally published on MedicalXpress.com
Drugs targeting the glucagon-like peptide 1 receptor (GLP-1R) offer several positive effects for individuals with type 2 diabetes, including the lowering of blood glucose and the reduction of body weight and of cardiovascular risk. In […]
When someone opens the door and enters a hospital room, wearing a stethoscope is a telltale sign that they’re a clinician. This medical device has been around for more than 200 years and remains a […]
A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk for the most common type of heart attack more accurately than existing methods. This could enable […]
Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic aneurysms—life-threatening bulges in the aorta’s abdominal section. However, it carries the risk of recurrence owing to endoleaks after stent graft implantation, […]
Previous studies have reported that a high consumption of ultra-processed foods is associated with an increased risk of developing cardiovascular diseases, while other studies have shown that a diet including a large proportion of plant-based […]
A new review published in Sleep Medicine Reviews sheds light on the biological mechanisms that may explain why patients with obstructive sleep apnea (OSA) face higher risks for heart disease, diabetes and other age-related conditions.This […]
Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for transplantation, […]
Faulty versions of the LMNA gene can cause a wide range of health problems, including heart muscle disease (dilated cardiomyopathy) and muscle weakness (muscular dystrophies). Many of these diseases are caused by single-point mutations, which […]
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF).This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca